Pharmaceuticals industry
222 companies · ₹9177.6 L cr · 60 with AI deep dives
5y revenue CAGR
median 9.37%(p25 2.98% · p75 14.46%)
5y avg ROCE
median 12.62%(p25 6.74% · p75 19.68%)
Debt / equity
median 0.25x(p25 0.07x · p75 0.51x)
The AI sector brief for this bucket is prepared once enough companies here have earnings-call coverage.
| Company | Mcap | AI verdict | Signals | Stated KPIs (latest call) |
|---|---|---|---|---|
| Ind-Swift Ltd | ₹8503.9 L cr | Unlock | earnings quality weak | |
| Satiate Agri Ltd | ₹646.9 L cr | Unlock | roce compounder | |
| Sun Pharmaceutical Industries Ltd | ₹4.7 L cr | Unlock | earnings quality strongnet cash | |
| Divis Laboratories Ltd | ₹2.0 L cr | Unlock | capex coming onlinepharma capex digesting | |
| Torrent Pharmaceuticals Ltd | ₹1.7 L cr | Unlock | latent operating leverageearnings quality stronglevering up | |
| Cipla Ltd | ₹1.2 L cr | Unlock | earnings quality strongnet cash | |
| Zydus Lifesciences Ltd | ₹1.1 L cr | Unlock | ||
| Lupin Ltd | ₹1.1 L cr | Unlock | earnings quality strong | |
| Mankind Pharma Ltd | ₹1.1 L cr | Unlock | latent operating leverageearnings quality strong | |
| Laurus Labs Ltd | ₹94,976 cr | Unlock | earnings quality strong | |
| Dr Reddys Laboratories Ltd | ₹94,790 cr | Unlock | latent operating leverageearnings quality strong | |
| Aurobindo Pharma Ltd | ₹89,707 cr | Unlock | capex coming onlineearnings quality strongpharma capex digesting | |
| Biocon Ltd | ₹70,386 cr | Unlock | earnings quality strongdeleveraging | |
| Alkem Laboratories Ltd | ₹67,387 cr | Unlock | ||
| Glenmark Pharmaceuticals Ltd | ₹61,808 cr | Unlock | earnings quality strong | |
| Abbott India Ltd | ₹59,286 cr | Unlock | roce compounder | |
| Ipca Laboratories Ltd | ₹45,413 cr | Unlock | earnings quality strongnet cash | |
| Glaxosmithkline Pharmaceuticals Ltd | ₹45,062 cr | Unlock | roce compounderearnings quality strong | |
| Ajanta Pharma Ltd | ₹41,675 cr | Unlock | roce compoundernet cash | |
| Gland Pharma Ltd | ₹40,168 cr | Unlock | latent operating leveragenet cash | |
| J B Chemicals & Pharmaceuticals Ltd | ₹38,731 cr | Unlock | roce compounderearnings quality strong | |
| Emcure Pharmaceuticals Ltd | ₹35,858 cr | Unlock | roce compounderearnings quality strong | |
| Wockhardt Ltd | ₹30,660 cr | Unlock | capex coming onlinedeleveragingpharma capex digesting | |
| Sai Life Sciences Ltd | ₹27,604 cr | Unlock | earnings quality strongnet cash | |
| Acutaas Chemicals Ltd | ₹27,092 cr | Unlock | capex coming onlinenet cashpharma capex digesting | |
| Piramal Pharma Ltd | ₹25,748 cr | Unlock | deleveraging | |
| Rubicon Research Ltd | ₹25,369 cr | Unlock | roce compounder | |
| Neuland Laboratories Ltd | ₹24,352 cr | Unlock | earnings quality strong | |
| Pfizer Ltd | ₹21,595 cr | Unlock | roce compoundernet cash | |
| Granules India Ltd | ₹21,141 cr | Unlock | earnings quality strong | |
| Astrazeneca Pharma India Ltd | ₹20,142 cr | Unlock | earnings quality weak | |
| OneSource Specialty Pharma Ltd | ₹19,804 cr | Unlock | ||
| Caplin Point Laboratories Ltd | ₹19,623 cr | Unlock | capex coming onlineroce compoundernet cashpharma capex digesting | |
| ERIS Lifesciences Ltd | ₹19,294 cr | Unlock | earnings quality strong | |
| Natco Pharma Ltd | ₹16,639 cr | Unlock | net cash | |
| Cohance Lifesciences Ltd | ₹16,297 cr | Unlock | latent operating leverageearnings quality strongnet cash | |
| Alembic Pharmaceuticals Ltd | ₹16,099 cr | Unlock | earnings quality strongpharma capex digesting | |
| Jubilant Pharmova Ltd | ₹15,371 cr | Unlock | capex coming onlineearnings quality strongdeleveragingpharma capex digesting | |
| Alivus Life Sciences Ltd | ₹13,534 cr | Unlock | capex coming onlineroce compoundercapex ahead of revenuepharma capex digesting | |
| Concord Biotech Ltd | ₹13,087 cr | Unlock | ||
| Corona Remedies Ltd | ₹12,599 cr | Unlock | capex coming onlineroce compounderearnings quality strongpharma capex digesting | |
| Shilpa Medicare Ltd | ₹11,839 cr | Unlock | capex coming onlineearnings quality strongpharma capex digesting | |
| Marksans Pharma Ltd | ₹11,646 cr | Unlock | net cash | |
| Procter & Gamble Health Ltd | ₹11,088 cr | Unlock | roce compounder | |
| Viyash Scientific Ltd | ₹11,081 cr | Unlock | latent operating leverageearnings quality strong | |
| Sanofi Consumer Healthcare India Ltd | ₹10,842 cr | Unlock | roce compounderearnings quality strong | |
| Akums Drugs & Pharmaceuticals Ltd | ₹10,416 cr | Unlock | earnings quality strongnet cash | |
| Blue Jet Healthcare Ltd | ₹9,931 cr | Unlock | capex coming onlineroce compounderpharma capex digesting | |
| Sudeep Pharma Ltd | ₹9,714 cr | Unlock | capex coming onlineroce compounderearnings quality weakpharma capex digesting | |
| Strides Pharma Science Ltd | ₹9,545 cr | Unlock | deleveragingpharma capex digesting | |
| Sanofi India Ltd | ₹7,761 cr | Unlock | roce compounder | |
| Jeena Sikho Lifecare Ltd | ₹7,035 cr | Unlock | roce compounderearnings quality strongnet cash | |
| Sun Pharma Advanced Research Company Ltd | ₹6,812 cr | Unlock | capex coming onlinepharma capex digesting | |
| Supriya Lifescience Ltd | ₹6,686 cr | Unlock | latent operating leverage | |
| FDC Ltd | ₹6,679 cr | Unlock | ||
| Aarti Pharmalabs Ltd | ₹6,130 cr | Unlock | latent operating leveragecapex coming onlineearnings quality strongcapex ahead of revenue | |
| Senores Pharmaceuticals Ltd | ₹6,108 cr | Unlock | capex coming onlineearnings quality weakpharma capex digesting | |
| Innova Captab Ltd | ₹5,464 cr | Unlock | ||
| Orchid Pharma Ltd | ₹5,001 cr | Unlock | capex coming onlineearnings quality strongcapex ahead of revenuepharma capex digesting | |
| Bliss GVS Pharma Ltd | ₹4,814 cr | Unlock | earnings quality strongnet cash | |
| RPG Life Sciences Ltd | ₹4,790 cr | Unlock | roce compounderearnings quality weaknet cash | |
| Zota Health Care Ltd | ₹4,427 cr | Unlock | latent operating leveragenet cash | |
| IOL Chemicals & Pharmaceuticals Ltd | ₹4,315 cr | Unlock | earnings quality strongnet cash | |
| Gufic BioSciences Ltd | ₹3,901 cr | Unlock | deleveraging | |
| Novartis India Ltd | ₹3,898 cr | Unlock | ||
| Gujarat Themis Biosyn Ltd | ₹3,874 cr | Unlock | latent operating leveragecapex coming onlineearnings quality strongcapex ahead of revenue | |
| Unichem Laboratories Ltd | ₹3,775 cr | Unlock | ||
| Aarti Drugs Ltd | ₹3,701 cr | Unlock | latent operating leverageearnings quality strongdeleveraging | |
| SMS Pharmaceuticals Ltd | ₹3,568 cr | Unlock | deleveragingpharma capex digesting | |
| Morepen Laboratories Ltd | ₹3,030 cr | Unlock | latent operating leverage | |
| Dishman Carbogen Amcis Ltd | ₹2,853 cr | Unlock | ||
| Kwality Pharmaceuticals Ltd | ₹2,682 cr | Unlock | ||
| Hikal Ltd | ₹2,679 cr | Unlock | latent operating leverageearnings quality strongdeleveragingcapital destroyer | |
| Panacea Biotec Ltd | ₹2,539 cr | Unlock | capex coming onlinenet cashpharma capex digesting | |
| Solara Active Pharma Sciences Ltd | ₹2,448 cr | Unlock | deleveraging | |
| Sai Parenterals Ltd | ₹2,425 cr | Unlock | capex coming onlineearnings quality strongpharma capex digesting | |
| Beta Drugs Ltd | ₹2,350 cr | Unlock | ||
| Hester Biosciences Ltd | ₹2,125 cr | Unlock | earnings quality strongdeleveraging | |
| Indoco Remedies Ltd | ₹2,105 cr | Unlock | latent operating leverageearnings quality stronglevering up | |
| Ind-Swift Laboratories Ltd | ₹2,066 cr | Unlock | net cash | |
| Venus Remedies Ltd | ₹2,046 cr | Unlock | earnings quality strongpharma capex digesting | |
| NGL Fine Chem Ltd | ₹1,986 cr | Unlock | capex coming onlinepharma capex digesting | |
| Sakar Healthcare Ltd | ₹1,889 cr | Unlock | earnings quality strong | |
| Windlas Biotech Ltd | ₹1,750 cr | Unlock | capex coming onlineearnings quality strongnet cashpharma capex digesting | |
| Fredun Pharmaceuticals Ltd | ₹1,493 cr | Unlock | roce compounder | |
| Amrutanjan Health Care Ltd | ₹1,477 cr | Unlock | capex coming onlinepharma capex digesting | |
| Jagsonpal Pharmaceuticals Ltd | ₹1,473 cr | Unlock | latent operating leverageearnings quality strong | |
| Shukra Pharmaceuticals Ltd | ₹1,356 cr | Unlock | capex coming onlineroce compounderearnings quality weaknet cash | |
| Fermenta Biotech Ltd | ₹1,337 cr | Unlock | earnings quality strong | |
| Syncom Formulations (India) Ltd | ₹1,230 cr | Unlock | net cash | |
| Lincoln Pharmaceuticals Ltd | ₹1,152 cr | Unlock | net cash | |
| Wanbury Ltd | ₹1,089 cr | Unlock | roce compounderdeleveraging | |
| Bajaj Healthcare Ltd | ₹1,071 cr | Unlock | earnings quality strongdeleveraging | |
| Bharat Parenterals Ltd | ₹1,043 cr | Unlock | net cash | |
| Themis Medicare Ltd | ₹976 cr | Unlock | earnings quality weakcyclical peak base | |
| Sigachi Industries Ltd | ₹971 cr | Unlock | latent operating leverage | |
| Kopran Ltd | ₹960 cr | Unlock | latent operating leverage | |
| Remus Pharmaceuticals Ltd | ₹843 cr | Unlock | capex coming onlineearnings quality weaknet cashpharma capex digesting | |
| Anlon Healthcare Ltd | ₹838 cr | Unlock | earnings quality weak | |
| Anuh Pharma Ltd | ₹804 cr | Unlock |